Application of 3-methoxyl mangiferin in preparing medicine used for treating post-stroke depression

A technology of methoxy mango, stroke, applied in the field of medicine

Active Publication Date: 2013-07-10
KPC PHARM INC
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the widely used antidepressants are selective serotonin uptake blockers, including fluoxetine, sequerin, paroxetine, etc., but due to well-known reasons, some adverse effects in the gastrointestinal tract Reactions, such as nausea, vomiting, anorexia, diarrhea, and its liver and kidney toxicity side effects, which limit the clinical appl...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 3-methoxyl mangiferin in preparing medicine used for treating post-stroke depression
  • Application of 3-methoxyl mangiferin in preparing medicine used for treating post-stroke depression
  • Application of 3-methoxyl mangiferin in preparing medicine used for treating post-stroke depression

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] 1 Experimental materials, reagents and instruments

[0037] Experimental animals: 40 healthy SD male rats, weighing (200+10) g, aged 5-6 months. Rats were adaptively fed in a mouse cage for 2 weeks, with free access to food and water, natural circadian rhythm light, and constant temperature (21±2)°C. During training, drink sucrose water and measure the baseline value of sucrose water test and open-field test (OFT), and select 32 rats with similar behavioral scores for the experiment.

[0038] Experimental drugs: 3-methoxymangiferin (Kunming Pharmaceutical, production batch number: 20111115), dissolved in 10% DMSO before use; fluoxetine hydrochloride (Prozac, production batch number: A019602), dissolved in distilled water before use , according to adult dosage (0.33mg·kg -1 d -1 ) 7 times the calculated dosage for rats (2.33mg·kg -1 d -1 ). Immunohistochemical reagents: rabbit anti-5-hydroxytryptamine (5-HT) produced by Beijing Zhongshan Biotechnology Co., Ltd., ra...

Embodiment 2

[0071] Example 2 3-methoxymangiferin freeze-dried powder injection

[0072] Prescription (1000 sticks):

[0073] 3-methoxymangiferin 1g

[0074] Meglumine 3g

[0075] Mannitol 2g

[0076] Packed into 1000 pieces, dissolved in water, and freeze-dried.

Embodiment 3

[0077] Example 3 3-methoxymangiferin freeze-dried powder injection

[0078] Prescription (1000 sticks):

[0079] 3-methoxymangiferin 100g

[0080] β-cyclodextrin 45g

[0081] Mannitol 1.31kg

[0082] Packed into 1000 pieces, dissolved in water, and freeze-dried.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of medicine, and discloses a novel application of 3-methoxyl mangiferin in the field of pharmacy, and a medicine composition comprising 3-methoxyl mangiferin. 3-methoxyl mangiferin can promote hippocampus dentate gyrus neuron 5-hydroxytryptamine 1A receptor gene and protein expressions, and can induce neurotrophic effects such as hippocampus remodeling performed by 5-hydroxytryptamine. Therefore, post-stroke hippocampus nerve aregeneratory can be substantially ameliorated, 5-HT re-uptake of nerve presynaptic membrane can be selectively inhibited, 5-HT positive cell expression at hypothalamus can be reduced, exhaustion of 5-HT can be relieved, and anxiety and depression symptoms caused by 5-HT exhaustion can be relieved. Therefore, 3-methoxyl mangiferin can be used in preparing medicines used for treating post-stroke depression.

Description

technical field [0001] The invention relates to the field of medicine, in particular to the application of 3-methoxymangiferin in the preparation of drugs for treating post-stroke depression. Background technique [0002] 3-Methoxymangiferin, full name 1,6,7-trihydroxy-3-methoxypyrrole-2-C-β-D-glucopyranoside, also known as homomangiferin, is a C-glycoside The xanthone compound exists in plants such as Anacardiaceae mango (Mangifera indica L.), almond (Mangifera persiciformis C.), and its structural formula is as shown in formula I: [0003] [0004] Post-stroke depression (PSD) is an organic affective disorder and one of the most common complications of stroke. It usually has a slow onset, protracted course, and serious harm, but its pathogenesis is still unclear. It is generally believed that the hypofunction of monoaminergic nerves in the brain is the pathophysiological basis of depression after cerebral hemorrhage. At present, the widely used antidepressants are sel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7048A61P25/24
Inventor 宋立明张伟高小惠杨旭娟
Owner KPC PHARM INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products